Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are preparing for a potential TV pharma ad ban.

Esteve Química's Juan Petit, CMO Business Spain Senior Director, and Andrea Oro, Global Head Commercial and Strategic ...

We recently published a list of the 12 Best Up and Coming Stocks to Buy According to Wall Street Analysts. In this article, ...

Mr. Camiolo brings to TScan demonstrated commercial readiness and cell therapy launch experienceWALTHAM, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a ...

Lytgobi is an FGFR inhibitor that received accelerated approval in 2022 to treat adults with previously treated, unresectable ...

FDA reviews TNX-102 SL for Fibromyalgia by August 2025, with no advisory required. See why we recommend a buy on TNXP stock.

San Diego, CA This invite-only summit, taking place at the luxurious Town and Country Resort in San Diego, CA, is designed ...

Esteve Química, the CDMO division of leading specialty pharmaceutical company ESTEVE, has been named the Champion of the 2025 CDMO Leadership Award in the Small Molecule API – Global Category. This ...

Highlighting deals by PE firms pursuing investments in marketing agencies focused on pharma and life sciences; insights on a ...

PE Hub rounded up five pharma marketing deals from the last five months, starting with the most recently announced. (We have ...

German drugmaker Grünenthal pushed its latest opioid as a safer option. People around the world got hooked. Madlen Davies, Hristio Boytchev, and Rafael Cabrera report.

HTA as described by the HTA Regulation is the multidisciplinary scientific evidence-based process that allows to determine the relative effectiveness of new or existing health technologies. HTA is a ...